Sponsored by:

Nuclear Medicine: Page 95

Blue Earth touts Axumin reader training results
By AuntMinnie.com staff writers
Molecular imaging firm Blue Earth Diagnostics is highlighting findings on the effect of standardized reader training for images acquired with its Axumin (fluciclovine F-18) PET radiopharmaceutical in men with prostate cancer.
May 4, 2017
PET/CT helps assess pediatric brain tumor therapy
By AuntMinnie.com staff writers
In a new study published in the May issue of the Journal of Nuclear Medicine, Dutch researchers are reporting success with whole-body PET/CT as a way to determine the efficacy of bevacizumab treatment for pediatric brain tumors known as diffuse intrinsic pontine glioma.
May 2, 2017
2017 05 03 10 15 32 328 Pet Ct Mri Jnm 20170503171557
Lantheus revenues climb in Q1
By AuntMinnie.com staff writers
Driven by strong sales of its Definity ultrasound contrast agent and TechneLite radiopharmaceutical, Lantheus Medical Imaging beat its worldwide revenue estimates for the first quarter of 2017.
May 2, 2017
PET probe shows promise for cancer treatment evaluation
By AuntMinnie.com staff writers
Researchers have combined PET scans with a newly developed probe to help determine the efficacy of cancer treatments, according to a study published April 30 in Cancer Research.
May 1, 2017
SNMMI publishes criteria for V/Q studies of PE
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria for ventilation/perfusion (V/Q) imaging for pulmonary embolism (PE).
May 1, 2017
Digirad revenue, income fall in Q1
By AuntMinnie.com staff writers
Buffeted by seasonal headwinds and changes to its mobile health platform, nuclear medicine firm Digirad said its revenue and income both fell for the first quarter, compared with the same period a year ago.
April 27, 2017
SPECT/CT for renal cell carcinoma | AI for tuberculosis | Retirement for radiologists
By Brian Casey
April 26, 2017
SPECT/CT can solve renal cell carcinoma diagnosis conundrum
By Wayne Forrest
By turning to a SPECT/CT scan with technetium-99m sestamibi, clinicians can overcome inconclusive or suspicious CT or MRI results and are better able to characterize and diagnose renal cell carcinoma, according to a study published in the April issue of Clinical Nuclear Medicine.
April 26, 2017
2017 04 26 15 03 02 411 2017 04 27 Tc 99m Sestamibi Thumb
Lantheus, GE finalize license agreement
By AuntMinnie.com staff writers
Lantheus Medical Imaging has signed a definitive agreement with GE Healthcare to support the worldwide development and commercialization of its flurpiridaz F-18 investigational PET radiopharmaceutical. The firms are also continuing their current supply agreement for other nuclear medicine products.
April 24, 2017
PET plays key role in preventive Alzheimer's study
By Wayne Forrest
With projections that the number of people living with Alzheimer's disease in the U.S. could more than triple by the year 2050, 65 research institutions are collaborating on a clinical trial using PET scans to identify the disease in its earliest stages, as well as guide the use of potential therapeutic agents.
April 18, 2017
2017 04 14 16 09 55 745 Amyloid Plaque Alzheimer 400
Cardinal Health provides cautionary fiscal outlook
By AuntMinnie.com staff writers
Hurt by price deflation from generic drugs, Cardinal Health said that fiscal 2017 profitability will be at the lower end of its previous guidance range. It also said that profit in its pharmaceutical segment could decline in fiscal 2018.
April 17, 2017
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
April 16, 2017
Previous Page
Page 95 of 438
Next Page